Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Luis Raez
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Luis Raez
671 views
June 14, 2024
Chapters
CROWN Trial & Lorlatinib FDA Approval
00:00
LAURA Study: Osimertinib in Stage III NSCLC
05:14
ADRIATIC: Durvalumab in Small Cell Lung Cancer
08:28
PALOMA Trial: Amivantamab Subcu vs IV
11:43
Survivability & Treatment Results Across Studies
14:47
Login to view comments.
Click here to Login